| http://www.w3.org/ns/prov#value | - ???The deficiencies described in the Form FDA 483 issued at the close of the inspection referenced above and this letter are an indication of your quality control unit not fulfilling its responsibility to assure the identity, strength, quality, and purity of your licensed biological drug product and intermediates,??? Malarkey added.
|
